NCT03739606 2020-12-17Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood CancerCity of Hope Medical CenterPhase 2 Withdrawn
NCT01652014 2016-07-14Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesRutgers, The State University of New JerseyPhase 2 Withdrawn